Company · CIK 1829667
Regencell Bioscience Holdings Ltd
| CIK | 1829667 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2833 — Medicinal Chemicals & Botanical Products |
| Incorporated in | E9 |
| Listed | RGC (Nasdaq) |
| First annual or quarterly report | 2021-10-29 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-254571 | 2021-03-22 | 2021-07-20 | 6 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-19 | 424B5Shelf takedown | 333-294722 | 0001213900-26-059114 |
| 2026-03-30 | 424B5Shelf takedown | 333-294722 | 0001213900-26-035916 |
| 2021-07-20 | 424B4Final prospectus | 333-254571 | 0001213900-21-037613 |
| 2021-07-15 | EFFECTDeclared effective | 333-254571 | 9999999995-21-002778 |
| 2021-06-23 | F-1/AAmendment | 333-254571 | 0001213900-21-033616 |
| 2021-06-11 | F-1/AAmendment | 333-254571 | 0001213900-21-032158 |
| 2021-04-26 | F-1/AAmendment | 333-254571 | 0001213900-21-022860 |
| 2021-03-22 | F-1Registration filed | 333-254571 | 0001213900-21-016917 |
| 2020-11-13 | DRSDraft made public | 377-03785 | 0001213900-20-037002 |